サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1393985

欧州のスマートライフサイエンス製造市場の2028年までの予測- 地域別分析- コンポーネント別、テクノロジー別、用途別

Europe Smart Life Sciences Manufacturing Market Forecast to 2028 - Regional Analysis - by Component (Solutions and Services), Technology, Application (Pharma, Bio-Pharma, and Medical Device)

出版日
ページ情報
英文 195 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
欧州のスマートライフサイエンス製造市場の2028年までの予測- 地域別分析- コンポーネント別、テクノロジー別、用途別
出版日: 2023年10月11日
発行: The Insight Partners
ページ情報: 英文 195 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のスマートライフサイエンス製造市場は、2023年の56億7,919万米ドルから2033年には220億5,287万米ドルに成長すると予測されています。2023年から2033年までのCAGRは14.5%と推定されます。

Pharma 4.0の採用が欧州のスマートライフサイエンス製造市場を後押し

医療分野ではテクノロジーが大きな役割を果たしており、腫瘍学、神経学、免疫学などの他の分野に比べて、バイオテクノロジー産業はデータ分析における最近の技術進歩によって最も恩恵を受けている分野です。新たなデータサイエンス技術もバイオテクノロジー産業の成長を支援しています。生物の分析、新薬の研究などは、バイオテクノロジー研究所が果たす主要な役割です。

最新のデータ分析ツールにより、バイオテクノロジー研究者は予測分析モデルを作成できるようになり、最終的には望ましい目標や目的を達成するための最も効果的な方法を理解できるようになっています。ビッグデータ、AI、バーチャルリアリティ、データ可視化、データセキュリティは、バイオテクノロジー研究所で使用される一般的な技術の一つです。デンマークのコペンハーゲン郊外のバッグスヴェルトに本社を置く大手バイオテクノロジー企業のノボザイムズは、データ可視化ツールのTableauを採用し、データ分析とコラボレーションのアプローチに革命をもたらしました。Tableauの導入により、Novozymes社はレポート作成時間を90%以上短縮することができました。また、販売、原材料購入、+計画、財務など、同社の各部門における戦略的な意思決定にも役立っています。さらに、TableauはNovozymesの営業部門が顧客と重要な洞察を共有することを可能にし、それによって関係を構築し、収益パフォーマンスを向上させています。

英スウェーデンの多国籍製薬・バイオテクノロジー企業であるAstraZeneca, plcは、データとテクノロジーを活用し、新薬候補の発見と提供までの時間を最短化しています。同社は、研究開発部門にデータサイエンスとAIの能力を組み込んでおり、科学者が科学の限界を押し広げ、生命を変える医薬品を提供することを可能にしています。ターゲット同定から臨床試験まで、創薬・開発プロセス全体を通じてAIを適用し、創薬・開発プロセスを導く新たな知見を明らかにしています。

Atomwiseは、低分子創薬におけるAIの活用に精通しています。2021年12月、同社は、がん、免疫、感染症、神経科学、凝固障害にまたがる研究プログラムを持つ新興ジョイントベンチャー企業の成長ポートフォリオを発表しました。感染症分野では、RNAウイルスの世界的エキスパートであるニト・パンガニバン氏との合弁会社vAirusを新たに設立することを発表しました。この合弁会社では、フラビウイルスに対する新規の広域抗ウイルス薬として作用する低分子化合物を見つけるために、AIベースのスクリーニングを使用します。電子カルテ（eHR）のような統合されたビッグデータツールは、ヘルスケア専門家が、患者の健康に関する情報が散在していたとしても、包括的な健康記録を容易に入手できるようにします。ビッグデータに裏打ちされた遺伝子調査の進歩は、鎌状赤血球症、嚢胞性線維症、血友病などの単一遺伝子疾患との闘いに劇的な進歩をもたらす可能性があります。この種の研究は、精神疾患や心臓病などの複雑な疾患に対する改善された治療法や予防戦略の開発にも利用できます。

欧州のスマートライフサイエンス製造市場の概要

欧州はスマート・ライフサイエンス製造の先進地域のひとつであり、インダストリー4.0は2011年にドイツ政府によって開始された第4の革命で、製造プロセスにおけるデジタル変化を表しています。国際製薬技術協会（ISPE）は2017年にPharma 4.0を導入し、製薬企業におけるデジタル技術の導入に総合的なアプローチをとっています。同地域では、スマート製造の高い導入率やライフサイエンスメーカー間の協力関係により、スマートライフサイエンス製造に大きな変化が見られ、今後数年間、欧州の市場成長を促進する可能性が高いです。2020年5月、欧州最大級の製薬メーカーであるアダメッド・グループは、セキュリティ、データ分析、機械学習、アプリ開発を含むマイクロソフト・アジュール・クラウド・プラットフォームの導入でプレディカと提携しました。プレディカは、AzureデータサービスとPower BIをベースとした完全に拡張可能なプラットフォームを設計・開発し、アダメッド社の自動予測生成、サプライチェーンとマーケティングの意思決定の最適化を支援しました。さらに2022年には、ポルトガルのCDMO（Contract Development and Manufacturing Organization）であるHovione社が、連続打錠を進めるためにGEAと協力しました。この戦略的提携は、GEAのエンジニアリングの専門知識とHovioneの開発・製造の経験を組み合わせたもので、両者は連続打錠技術の採用を加速するために提携することを約束しています。

COVID-19の大流行により、特に人工呼吸器、病院用ベッド、医薬品、ワクチンの製造において、スマート製造技術の採用と導入が増加しました。このため、医療機器や医薬品の製造・承認に関するこの地域の規制方針は大きく変化しました。欧州議会は医療機器指令に代わって規制を導入しました。パンデミックのため、メーカーはこの地域の規制適用に関する規定を改正しました。低リスクの医療機器については、指令から規制への移行期間が2027年5月まで延長され、中リスクの医療機器については2026年5月まで延長されています。また、高リスク機器の移行期間は2025年5月まで延長されます。医療機器におけるデジタル自動化は、規制を遵守し、承認を容易に処理するのに役立ち、承認時間を短縮し、タイムリーな製品発売を支援します。規制シナリオの変化、ライフサイエンス製造におけるデジタル技術の高い採用率、市場プレイヤー間の協力関係の高まりは、予測期間中に欧州のスマートライフサイエンス製造市場の成長を増大させると予想されます。

欧州のスマートライフサイエンス製造市場の収益と2033年までの予測（百万米国ドル）

欧州のスマートライフサイエンス製造市場のセグメンテーション

欧州のスマートライフサイエンス製造市場は、技術、コンポーネント、アプリケーション、国に区分されます。

コンポーネントに基づき、欧州のスマートライフサイエンス製造市場はソリューションとサービスに区分されます。2023年の欧州のスマートライフサイエンス製造市場では、ソリューションセグメントが大きなシェアを占めています。

技術に基づき、欧州のスマートライフサイエンス製造市場セグメントは、AR/VRシステム、モノのインターネット（IoT）、人工知能（AI）、サイバーセキュリティ、ビッグデータ、その他に分類されます。2023年の欧州のスマートライフサイエンス製造市場では、モノのインターネット分野が最大のシェアを占めています。

用途に基づき、欧州のスマートライフサイエンス製造市場は製薬、バイオ製薬、医療機器に区分されます。医療機器セグメントが2023年の欧州のスマートライフサイエンス製造市場で最大のシェアを占めています。

国別では、欧州のスマートライフサイエンス製造市場はドイツ、フランス、イタリア、スペイン、英国、その他欧州に区分されます。2023年の欧州のスマートライフサイエンス製造市場はドイツが独占。

ABB Ltd、Bosch Rexroth AG、Emerson Electric Co、Fortinet Inc、General Electric Co、Honeywell International Inc、International Business Machines Corp、Rockwell Automation Inc、Siemens AG、Sophos Ltdは、欧州のスマートライフサイエンス製造市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 欧州のスマートライフサイエンス製造市場-主要な要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のスマートライフサイエンス製造市場- 市場情勢

  • 概観
  • 欧州PEST分析
  • エコシステム分析
  • 専門家の見解

第5章 欧州のスマートライフサイエンス製造市場：主要市場力学

  • 市場促進要因
    • ファーマ4.0の導入拡大
    • バイオテクノロジー研究所における技術利用の増加
  • 市場抑制要因
    • スキルギャップの存在と高額な初期投資の必要性
  • 市場機会
    • がん研究における人工知能の利用
    • スマート工場におけるバーチャルリアリティの採用
  • 今後の動向
    • データサイロへの接続
    • ブロックチェーンの利用
    • エッジコンピューティング
    • 予知保全
    • ビジョンベースの品質管理
    • スマートファクトリーの動向
    • インダストリー5.0の出現
  • 促進要因と抑制要因の影響分析

第6章 欧州のスマートライフサイエンス製造市場- 欧州分析

第7章 欧州のスマートライフサイエンス製造市場分析-コンポーネント別

  • 欧州のスマートライフサイエンス製造市場：コンポーネント別（2022年、2033年）
  • ソリューション
  • サービス

第8章 欧州のスマートライフサイエンス製造市場分析-技術別

  • 欧州のスマートライフサイエンス製造市場：技術別（2022年、2033年）
  • AR/VRシステム
  • モノのインターネット（IOT）
  • 人工知能
  • サイバーセキュリティ
  • ビッグデータ
  • その他

第9章 欧州のスマートライフサイエンス製造市場分析-最終用途産業別

  • 欧州のスマートライフサイエンス製造市場：最終用途産業別（2022年、2033年）
  • 製薬
  • バイオファーマ
  • 医療機器

第10章 欧州のスマートライフサイエンス製造市場分析：国別

  • 欧州のスマートライフサイエンス製造市場概要

第11章 業界情勢

  • 市場の取り組み、拡大、戦略的開発
  • 新製品/機能開発
  • 合併と買収
  • 契約、提携、合弁事業

第12章 企業プロファイル

  • ABB Ltd
  • Bosch Rexroth AG
  • Emerson Electric Co
  • Fortinet Inc
  • General Electric Co
  • Honeywell International Inc
  • International Business Machines Corp
  • Rockwell Automation Inc
  • Siemens AG
  • Sophos Ltd.

第13章 付録

図表

List Of Tables

  • Table 1. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Table 2. Germany Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 3. Germany Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 4. Germany Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 5. Germany Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 6. France Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 7. France Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 8. France Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 9. France Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 10. Italy Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 11. Italy Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 12. Italy Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 13. Italy Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 14. UK Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 15. UK Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 16. UK Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 17. UK Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 18. Spain Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 19. Spain Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 20. Spain Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 21. Spain Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 22. Rest of Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
  • Table 23. Rest of Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
  • Table 24. Rest of Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
  • Table 25. Rest of Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
  • Table 26. List of Abbreviation

List Of Figures

  • Figure 1. Europe Smart Life Sciences Manufacturing Market Segmentation
  • Figure 2. Europe Smart Life Sciences Manufacturing Market Segmentation, By Country
  • Figure 3. Europe Smart Life Sciences Manufacturing Market Overview
  • Figure 4. Solutions Held Largest Share of Component Segment in Europe Smart Life Sciences Manufacturing Market
  • Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Europe Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 10. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
  • Figure 11. Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 12. Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 13. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
  • Figure 14. AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 15. Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 16. Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 17. Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 18. Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 19. Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 20. Europe Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
  • Figure 21. Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 22. Bio-Pharma : Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 23. Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • Figure 24. Europe Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. Europe Smart Life Sciences Manufacturing Market, Revenue Share, by Key Country, (2022 & 2033)
  • Figure 26. Germany: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 27. France: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 28. Italy: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 29. UK: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 30. Spain: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
  • Figure 31. Rest of Europe: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
目次
Product Code: BMIRE00028923

The Europe smart life sciences manufacturing market is expected to grow from US$ 5,679.19 million in 2023 to US$ 22052.87 million by 2033. It is estimated to grow at a CAGR of 14.5% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel Europe Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.

Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Novozymes, a leading biotechnology company headquartered in Bagsværd, just outside of Copenhagen, Denmark, has adopted Tableau, a data visualization tool, which revolutionized its approach to data analysis and collaboration. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.

Atomwise has expertise in using AI in small-molecule drug discovery. In December 2021, the company announced its growing portfolio of emerging joint venture companies, with research programs spanning oncology, immunology, infectious disease, neuroscience, and clotting disorders. In the area of infectious disease, the company announced the addition of vAirus, a newly formed joint venture company with world RNA-virus expert Nito Panganiban. The joint venture will use AI-based screening to find small molecule compounds to act as novel broad-spectrum antivirals against flaviviruses. Integrated big data tools such as electronic health records (eHR) can make it easy for healthcare professionals to obtain a comprehensive patient health record, even if information regarding their health originates from scattered sources. Other advances in genetic research backed by big data could lead to dramatic progress in the fight against single-gene disorders, such as sickle cell disease, cystic fibrosis, and hemophilia. This type of research can also be employed to develop improved treatments and prevention strategies for complex conditions such as mental illness and heart disease.

Europe Smart Life Sciences Manufacturing Market Overview

Europe is one of the developed regions for smart life sciences manufacturing, and Industry 4.0 is the fourth revolution started in 2011 by the German government to describe the digital changes in the manufacturing process. The International Society of Pharmaceutical Engineering (ISPE) introduced Pharma 4.0 in 2017, which takes a holistic approach to the implementation of digital technology in pharmaceutical enterprises. The region has seen significant changes in smart life sciences manufacturing owing to the high implementation of smart manufacturing and collaborations among life sciences manufacturers are likely to propel the market growth in Europe in the coming years. In May 2020, Adamed Group, one of the largest pharmaceutical manufacturers in Europe, partnered with Predica for the deployment of Microsoft Azure cloud platform, including security, data analytics, machine learning, and app development. Predica designed and developed a fully extensible platform based on Azure data services and Power BI that helped Adamed generate automated forecasts and optimize its supply chain and marketing decisions. Additionally, in 2022, Hovione, one the Contract Development and Manufacturing Organization (CDMO) from Portugal, collaborated with GEA to advance continuous tableting. This strategic collaboration combines GEA's engineering expertise with Hovione's development and manufacturing experience, and both parties commit to partner to accelerate the adoption of continuous tableting technology.

COVID-19 pandemic has increased the adoption and implementation of smart manufacturing technologies, especially for the production of ventilators, hospital beds, drugs, and vaccines. This led to a significant change in the regulatory policies of the region for the production and approval of medical devices and drugs. The European Parliament has replaced medical device directives with regulations. Owing to the pandemic, the manufacturers have amended provisions for the application of regulations in the region. For low-risk devices, the transition period from directive to regulation is extended until May 2027, and for moderate-risk devices, the period is extended until May 2026. Also, the transition period for high-risk devices is extended until May 2025. Digital automation in medical devices helps comply with the regulation and easily process approval, which reduces the approval time and assists in timely product launches. The changing regulatory scenario, high adoption rate of digital technology in life sciences manufacturing, and rising collaborations among market players are expected to augment the Europe smart life sciences manufacturing market growth in Europe during the forecast period.

Europe Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

Europe Smart Life Sciences Manufacturing Market Segmentation

The Europe smart life sciences manufacturing market is segmented into technology, component, application, and country.

Based on component, the Europe smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the Europe smart life sciences manufacturing Market in 2023.

Based on technology, the Europe smart life sciences manufacturing market segment is categorized into AR/VR Systems, Internet of things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on application, the Europe smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical devices segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on country, the Europe smart life sciences manufacturing market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the Europe smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the Europe smart life sciences manufacturing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Smart Life Sciences Manufacturing Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Smart Life Sciences Manufacturing Market - By Component
    • 1.3.2 Europe Smart Life Sciences Manufacturing Market - By Technology
    • 1.3.3 Europe Smart Life Sciences Manufacturing Market - By End Use Industry
    • 1.3.4 Europe Smart Life Sciences Manufacturing Market - By Country

2. Europe Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Smart Life Sciences Manufacturing Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Ecosystem Analysis
  • 4.4 Expert Opinion

5. Europe Smart Life Sciences Manufacturing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Adoption of Pharma 4.0
    • 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
  • 5.2 Market Restraints
    • 5.2.1 Presence of Skill Gap and Need for High Initial Investment
  • 5.3 Market Opportunities
    • 5.3.1 Use of Artificial Intelligence in Cancer Research
    • 5.3.2 Adoption of Virtual Reality in Smart Factory
  • 5.4 Future Trends
    • 5.4.1 Connection to Data Silos
    • 5.4.2 Usage of Blockchain
    • 5.4.3 Edge Computing
    • 5.4.4 Predictive Maintenance
    • 5.4.5 Vision-Based Quality Management
    • 5.4.6 Smart Factory Trends
    • 5.4.7 Emergence of Industry 5.0
  • 5.5 Impact Analysis of Drivers and Restraints

6. Europe Smart Life Sciences Manufacturing Market - Europe Analysis

  • 6.1 Overview
  • 6.2 Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. Europe Smart Life Sciences Manufacturing Market Analysis - By Component

  • 7.1 Overview
  • 7.2 Europe Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
  • 7.3 Solutions
    • 7.3.1 Overview
    • 7.3.2 Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 7.4 Services
    • 7.4.1 Overview
    • 7.4.2 Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. Europe Smart Life Sciences Manufacturing Market Analysis - By Technology

  • 8.1 Overview
  • 8.2 Europe Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
  • 8.3 AR/VR System
    • 8.3.1 Overview
    • 8.3.2 AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 8.4 Internet of Things (IOT)
    • 8.4.1 Overview
    • 8.4.2 Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 8.5 Artificial Intelligence
    • 8.5.1 Overview
    • 8.5.2 Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 8.6 Cyber Security
    • 8.6.1 Overview
    • 8.6.2 Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 8.7 Big Data
    • 8.7.1 Overview
    • 8.7.2 Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. Europe Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

  • 9.1 Overview
  • 9.2 Europe Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
  • 9.3 Pharma
    • 9.3.1 Overview
    • 9.3.2 Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 9.4 Bio-Pharma
    • 9.4.1 Overview
    • 9.4.2 Bio-Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
  • 9.5 Medical Device
    • 9.5.1 Overview
    • 9.5.2 Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. Europe Smart Life Sciences Manufacturing Market Analysis - By Country

  • 10.1 Europe Smart Life Sciences Manufacturing Market Overview
      • 10.1.1.1 Germany: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.1.3 Germany: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.1.4 Germany: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.1.4.1 Germany: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.1.5 Germany: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
      • 10.1.1.2 France: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 France: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.2.3 France: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.2.4 France: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.2.4.1 France: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.2.5 France: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
      • 10.1.1.3 Italy: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Italy: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.3.3 Italy: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.3.4 Italy: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.3.4.1 Italy: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.3.5 Italy: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
      • 10.1.1.4 UK: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 UK: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.4.3 UK: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.4.4 UK: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.4.4.1 UK: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.4.5 UK: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
      • 10.1.1.5 Spain: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.5.3 Spain: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.5.4 Spain: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.5.4.1 Spain: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.5.5 Spain: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
      • 10.1.1.6 Rest of Europe: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
        • 10.1.1.6.4.1 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Market Initiatives, Expansions, and Strategic Developments
  • 11.3 New Product/Feature Development
  • 11.4 Mergers and Acquisitions
  • 11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

  • 12.1 ABB Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bosch Rexroth AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Emerson Electric Co
    • 12.3.1 Business Description
    • 12.3.2 Products and Services
    • 12.3.3 Financial Overview
    • 12.3.4 SWOT Analysis
    • 12.3.5 Key Developments
  • 12.4 Fortinet Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 General Electric Co
    • 12.5.1 Business Description
    • 12.5.2 Products and Services
    • 12.5.3 Financial Overview
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 Honeywell International Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 International Business Machines Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Rockwell Automation Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Siemens AG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Sophos Ltd.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Word Index